These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28857677)

  • 1. Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?
    Chong Y; Ikematsu H
    Hum Vaccin Immunother; 2018 Mar; 14(3):518-522. PubMed ID: 28857677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
    DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
    Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
    Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal influenza vaccines, science fiction or soon reality?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.
    Catani JPP; Smet A; Ysenbaert T; Vuylsteke M; Bottu G; Mathys J; Botzki A; Cortes-Garcia G; Strugnell T; Gomila R; Hamberger J; Catalan J; Ustyugova IV; Farrell T; Stegalkina S; Ray S; LaRue L; Saelens X; Vogel TU
    Elife; 2024 May; 12():. PubMed ID: 38805550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
    Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
    Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.
    Dinis JM; Florek KR; Fatola OO; Moncla LH; Mutschler JP; Charlier OK; Meece JK; Belongia EA; Friedrich TC
    J Virol; 2016 Jan; 90(7):3355-65. PubMed ID: 26739054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.
    Tewawong N; Suntronwong N; Vichiwattana P; Vongpunsawad S; Theamboonlers A; Poovorawan Y
    Virus Genes; 2016 Oct; 52(5):711-5. PubMed ID: 27146171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed selection of amino acid changes in the influenza hemagglutinin and neuraminidase affecting protein antigenicity.
    DeDiego ML; Chiem K; Topham DJ
    Vaccine; 2018 Oct; 36(43):6383-6392. PubMed ID: 30224200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties.
    Strengell M; Ikonen N; Ziegler T; Julkunen I
    PLoS One; 2011; 6(10):e25848. PubMed ID: 22022458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants.
    Chong Y; Ikematsu H
    Vaccine; 2017 Jan; 35(2):255-263. PubMed ID: 27919631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.
    Tewawong N; Prachayangprecha S; Vichiwattana P; Korkong S; Klinfueng S; Vongpunsawad S; Thongmee T; Theamboonlers A; Poovorawan Y
    PLoS One; 2015; 10(10):e0139958. PubMed ID: 26440103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial Protection Induced by 2011-2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People.
    Camilloni B; Basileo M; Menculini G; Tozzi P; Iorio AM
    Adv Exp Med Biol; 2016; 897():45-53. PubMed ID: 26577530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of antigenically advanced variants of seasonal influenza viruses.
    Li C; Hatta M; Burke DF; Ping J; Zhang Y; Ozawa M; Taft AS; Das SC; Hanson AP; Song J; Imai M; Wilker PR; Watanabe T; Watanabe S; Ito M; Iwatsuki-Horimoto K; Russell CA; James SL; Skepner E; Maher EA; Neumann G; Klimov AI; Kelso A; McCauley J; Wang D; Shu Y; Odagiri T; Tashiro M; Xu X; Wentworth DE; Katz JM; Cox NJ; Smith DJ; Kawaoka Y
    Nat Microbiol; 2016 May; 1(6):16058. PubMed ID: 27572841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticipating time-dependent antigenic variants of influenza A (H3N2) viruses.
    Adabor ES
    Infect Genet Evol; 2019 Jan; 67():67-72. PubMed ID: 30391719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza H3N2 Vaccines: Recent Challenges.
    Mostafa A; Pleschka S
    Trends Microbiol; 2018 Feb; 26(2):87-89. PubMed ID: 29268980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011.
    Ann J; Papenburg J; Bouhy X; Rhéaume C; Hamelin MÈ; Boivin G
    J Clin Virol; 2012 Jan; 53(1):88-92. PubMed ID: 22036039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.
    Abente EJ; Santos J; Lewis NS; Gauger PC; Stratton J; Skepner E; Anderson TK; Rajao DS; Perez DR; Vincent AL
    J Virol; 2016 Sep; 90(18):8266-80. PubMed ID: 27384658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.